CRIS

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 2.38 M2.75 M3.18 M1.14 M00 4.31 M Gross profit 2.38 M2.75 M3.18 M1.14 M00 4.31 M Operating expenses 12.54 M11 M10.1 M8.71 M11.52 M3.23 M 33.56 M Selling/general/admin expenses 3.98 M3.53 M3.65 M2.88 M5.07 M3.23 M 14.83 M Research & development 8.54 M7.46 M6.43 M5.83 M6.45 M6.71 M 25.42 M Operating income -10.16 M-8.25 M-6.92 M19.62 M-11.52 M-9.94 M -8.76 M Non-Operating Income, Total -459 K-342 K-805 K-263 K-12.68 M1.36 M -12.39 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -459 K-342 K-805 K-263 K-12.68 M1.36 M -12.39 M Unusual income/expense —————— — Pretax income -10.62 M-8.59 M-7.73 M19.36 M-24.2 M-8.58 M -21.15 M Equity in earnings —————— — Taxes ———2.53 M—— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -10.62 M-8.59 M-7.73 M19.36 M-24.2 M-8.58 M -21.15 M Discontinued operations —————— — Net income -10.62 M-8.59 M-7.73 M19.36 M-24.2 M-8.58 M -21.15 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -10.62 M-8.59 M-7.73 M19.36 M-24.2 M-8.58 M -21.15 M Basic earnings per share (Basic EPS) -25-13.6-9.836.81-25-4.02 -2.01 Diluted earnings per share (Diluted EPS) -25-13.6-9.836.81-25-4.02 -2.01 Average basic shares outstanding 424.69 K631.38 K784.01 K658.2 K968.17 K2.14 M — Diluted shares outstanding 424.69 K631.38 K784.01 K658.2 K968.17 K2.14 M — EBITDA -10.16 M-8.25 M-6.92 M-7.57 M—— — EBIT -10.16 M-8.25 M-6.92 M-7.57 M-11.52 M-9.94 M -35.95 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 0000—— —